Amyotrophic Lateral Sclerosis (ALS) is a rapidly progressive disease with no known cure. It is a neurodegenerative disease, where inflammation and oxidative stress result in the death of neurons. The current treatments do not cure the disease, they only provide a moderate improvement in the symptoms.Cannabinoids and terpenes have repeatedly demonstrated their anti-oxidative, anti-inflammatory, and neuroprotective properties. Based on in silico studies and published scientific research, we are creating a combination of non-psychoactive cannabinoids. This combination should* provide substantial relief from the ALS symptoms while slowing disease progression.This cannabinoid formulation will provide a more effective solution to the current cannabinoid-based…